trending Market Intelligence /marketintelligence/en/news-insights/trending/kWb_GxdaJTvwsmoO0yM09g2 content esgSubNav
In This List

Imprimis Pharmaceuticals changes name to Harrow Health

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Imprimis Pharmaceuticals changes name to Harrow Health

Imprimis Pharmaceuticals Inc. said it changed its name to Harrow Health Inc. and will trade as HROW on the Nasdaq Capital Markets beginning Jan. 2, 2019.

Harrow Health owns a portfolio of healthcare businesses, including an ophthalmology pharmaceutical compounding business called ImprimisRx.